Table 1.
Current canine vaccine (NOAH Compendium 2014) and VMD listings
| Manufacturer | Name | Target | Core/Non‐core | Possible Co‐administration | Administration |
|---|---|---|---|---|---|
| C+ = Core + CPIV | |||||
| Merial | Eurican DHPPi | CDV, CAV, CPV, CPiV | C | Eurican L | Subcutaneous |
| Eurican P | CPV | C | Eurican L | Subcutaneous | |
| Eurican L | Leptospira | C | Eurican DHppi / Eurican P | Subcutaneous | |
| Rabisin | Rabies subunit | N | N/A | Subcutaneous | |
| Eurican Herpes 205 | CHV subunit | N | N/A | Subcutaneous | |
| MSD Animal Health | Nobivac KC | Bordetella bronchiseptica, CPiV | N | N/A | Intranasal |
| Nobivac DHP | CDV, CAV, CPV | C | Nobivac Rabies/ Nobivac L | Subcutaneous | |
| Nobivac DHPPI | CDV, CAV, CPV, CPiV | C+ | Nobivac Rabies/ Nobivac L | Subcutaneous | |
| Nobivac Parvo‐C | CPV | C | Nobivac Rabies/ Nobivac L | Subcutaneous | |
| Nobivac Rabies | Inactivated rabies | N | Nobivac DHP/ Nobivac DHPPI/ Nobivac Parvo‐C | Subcutaneous | |
| Nobivac L | Killed Leptospira | C | Nobivac DHP/ Nobivac DHPPI/ Nobivac Parvo‐C | Subcutaneous | |
| Nobivac Lepto 2 | Subunit Leptospira | C | N/A | Subcutaneous | |
| Nobivac Pi | CPiV | N | N/A | Subcutaneous | |
| Zoetis Animal Health | Bronchi‐ Shield | Bordetella bronchiseptica | N | N/A | Intranasal |
| Duramune DAP | CDV, CAV, CPV | C | N/A | Subcutaneous | |
| Duramune DAP+L | CDV, CAV, CPV, Leptospira | C | N/A | Subcutaneous | |
| Duramune DAPPi | CDV, CAV, CPV, CPiV, | C+ | N/A | Subcutaneous | |
| Duramune DAPPi+L | CDV, CAV, CPV, CPiV, Leptospira | C+ | N/A | Subcutaneous | |
| Duramune DAPPi+LC | CDV, CAV, CPV, CPiV, CCoV, Leptospira | C+ | N/A | Subcutaneous | |
| Duramune Puppy DP+C | CDV, CPV, CCoV | C | N/A | Subcutaneous | |
| DuramunePi | CPiV | N | N/A | Subcutaneous | |
| DuramunePi +L | CPiV, Leptospira | C+ | N/A | Subcutaneous | |
| DuramunePi +LC | CPiV, CCoV, Leptospira | C+ | N/A | Subcutaneous | |
| Vanguard 7 | CDV, CAV, CPV, CPiV, Leptospira | C+ | N/A | Subcutaneous | |
| Vanguard CPV | CPV | C | N/A | Subcutaneous | |
| Vanguard CPV‐L | CPV, Leptospira | C | N/A | Subcutaneous | |
| Vanguard L | Leptospira | C | N/A | Subcutaneous | |
| Vanguard Rabies | Inactivated rabies | N | N/A | Subcutaneous | |
| Virbac | Canigen KC | Bordetella bronchiseptica, CPiV | N | N/A | Intranasal |
| Canigen DHP | CDV, CAV, CPV | C | Canigen Rabies/ Canigen Lepto | Subcutaneous | |
| Canigen DHPi | CDV, CAV, CPV, CPiV | C+ | Canigen Rabies/ Canigen Lepto | Subcutaneous | |
| Canigen ParvoC | CPV | C | Canigen Rabies/ Canigen Lepto | Subcutaneous | |
| Canigen Pi | CPiV | N | Canigen Rabies/ Canigen Lepto | Subcutaneous | |
| Canigen Rabies | Inactivated rabies | N | Canigen DHP/ Canigen DHPi/ Canigen ParvoC/ Canigen Pi | Subcutaneous | |
| Canigen Lepto 2 | Killed Leptospira | C | Canigen DHP/ Canigen DHPi/ Canigen ParvoC/ Canigen Pi | Subcutaneous | |
| Canixin DHPPi/L | CDV, CAV, CPV, CPiV, Leptospira | C+ | N/A | Subcutaneous | |
| CaniLeish | Leishmania subunit | C | N/A | Subcutaneous |
CAV, canine adenovirus; CDV, canine distemper virus; CHV, canine herpes virus; CPiV, canine parainfluenza virus; CPV, canine parvovirus; NOAH, National Office of Animal Health; VMD, Veterinary Medicines Directorate.